MedTrace Logo

'Go With the Flow': Effects of Mindful Self-Compassion in Psychiatric Rehabilitation

NCT04917081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2022-04-06

No results posted yet for this study

Summary

This study is designed as a randomized controlled trial to gain further insights into possible effects of a standardized 6-week Mindful Self-Compassion (MSC) training on psychiatric rehabilitation inpatients and aims

* to generate insights into which parameters of mental health, and especially emotion regulation, can be improved by MSC in this setting,
* to compare effects of MSC training with an established relaxation training (i.e., progressive muscle relaxation; PMR) and
* to determine the general conditions and patient characteristics influencing the effectiveness of MSC training.

Conditions

  • Meditation
  • Progressive Muscle Relaxation

Interventions

BEHAVIORAL

Mindful Self-Compassion

Mindful Self-Compassion has been developed by Neff and Germer as a specific kind of Mindfulness-Based Interventions to promote self-compassion. It combines the skills of mindfulness and self-compassion, providing a powerful tool for emotional resilience and enhancing the capacity for emotional wellbeing. In this study, a shortened version of the MSC program is used which is applied once a week for 75 minutes throughout the patients' stay in the rehabilitation clinic.

BEHAVIORAL

Progressive Muscle Relaxation

Progressive Muscle Relaxation by Jacobson is a deep relaxation technique that helps relieve muscle tension and is based on the premise that mental calmness is a natural result of physical relaxation. In this study, Progressive Muscle Relaxation is applied once a week for 75 minutes throughout the patients' stay in the rehabilitation clinic.

Sponsors & Collaborators

  • pro mente REHA

    collaborator OTHER

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Human-Friedrich Unterrainer, PD DDr. · Medical University Graz, Department of Psychiatry and Psychotherapeutic Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2021-08-11
Completion
2021-08-11

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04917081 on ClinicalTrials.gov